CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
120944-16-3 | 2(3h)-oxazolone, 5-(2-(4-(2,5-dichlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluorop | |
| |
120944-15-2 | 2(3h)-oxazolone, 5-(2-(4-(4-chlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluoropheny | |
| |
120944-14-1 | 2(3h)-oxazolone, 5-(2-(4-(3-chlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluoropheny | |
| |
120944-13-0 | 2(3h)-oxazolone, 5-(2-(4-(2-chlorophenyl)-1-piperazinyl)ethyl)-4-(4-fluoropheny | |
| |
120944-12-9 | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(3-(trifluoromethyl)phenyl)-1-piper | |
| |
120944-11-8 | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(4-methoxyphenyl)-1-piperazinyl)eth | |
| |
120944-10-7 | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(3-methoxyphenyl)-1-piperazinyl)eth | |
| |
120944-09-4 | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(3-methylphenyl)-1-piperazinyl)ethy | |
| |
120944-08-3 | 2(3h)-oxazolone, 4-(4-fluorophenyl)-5-(2-(4-(2-methylphenyl)-1-piperazinyl)ethy | |
| |
120943-07-9 | fmoc-pro-phe-oh | |
C2H28N2O5 | 160.25 |
120940-43-4 | n-methyl-n-[2-nitro-4-(trifluoromethyl)phenyl]hydrazine | 熔点:68-70℃
|
C8H8F3N3O2 | 235.16 |
120939-52-8 | n-butyl-aminopropyl-dimthoxymethyl-silane | |
C10H25NO2Si | 219.39 |
120937-44-2 | di-tert-butylcyclopentadiene, mixture of isomers | |
C13H22 | 178.31 |
120934-96-5 | fpl 64176 | 熔点:144 - 145 °C
|
C22H21NO3 | 347.41 |
120930-83-8 | notechis 11'2 | |
| |
12093-10-6 | 甲醛二茂铁 Cyclopentadienyl(formylcyclopentadienyl)iron | 熔点:120-124℃
|
C11H10FeO | 214.04 |
12093-05-9 | tricarbonyl(cyclooctatetraene)iron | 熔点:93-95℃
|
C11H8FeO3 | 244.02 |
120928-88-3 | allatotropin | |
C65H103N19O17S2 | 1486.76 |
120928-15-6 | kerosine (petroleum), polymn. | |
| |
120928-09-8 | 4-((4-(1,1-dimethylethyl)phenyl)ethoxy)-quinazolin | 沸点:64.7 °C(甲醇)
|
C20H22N2O | 306.4 |
120928-08-7 | pro-leu-gly hydroxamate hydrochloride | |
C13H24N4O4.HCl | 336.81 |
120928-04-3 | b-endothelin | |
C116H161N27O32S4 | 2573.95 |
120928-03-2 | vasoactive intestinal peptide fragment*1-12 human | |
C61H88N18O22 | 1425.47 |
120928-02-1 | ala-phe-lys 7-amido-4-methylcoumarin | |
C28H35N5O5 | 521.61 |
120927-96-0 | polyadenylic acid-decathymidylic acid*sodium | |
| |
120925-60-2 | na 0345 | |
| |
12092-47-6 | 氯(1,5-环辛二烯)铑二聚 Bis(1,5-cyclooctadiene)dirhodium(I)dichloride | 熔点:243℃
|
C16H24Cl2Rh2 | 493.08 |
120919-04-2 | amonabactin t | |
| |
120919-03-1 | amonabactin p | |
| |
120912-54-1 | 5,6-dichlorobenzimidazole riboside-3',5'-monophosphorothioate,sp-isomer(sp 5,6-dcl-cbimps), | |
| |
120912-37-0 | 5-INDANYL ISOCYANATE | |
| |
12091-84-8 | 2,4-dinitrophenyl ferrocene | |
| |
12091-64-4 | 双(三羰基环戊二烯钼) Cyclopentadienylmolybdenum(II)tricarbonyl,dimer | 熔点:222℃
|
C16H10Mo2O6 | 490.13 |
120908-95-4 | isoquinolinium, 2-(6-((2-heptadecyl-2-methyl-1,3-dioxolan-4-yl)methoxy)-6-oxohe | |
| |
120908-94-3 | quinolinium, 1-(6-((2-heptadecyl-2-methyl-1,3-dioxolan-4-yl)methoxy)-6-oxohexyl | |
| |
120904-94-1 | polyubiquitin | |
| |
120904-46-3 | 5,12-dihydroxy-6,8,14-eicosatrienoic acid | |
| |
120901-49-7 | propanoic acid, 2-methyl-, 1,2-bis(acetyloxy)-5-cyano-2,3,4,5,6,11-hexahydro-3, | |
| |
1209-98-9 | n-ethyl-3-phenyl-2-norbornanamin | |
| |
1209-84-3 | 1,8-naphthalenedicarboxylic acid, dipotassium salt | |
| |
1209-66-1 | phenothiazine s,s-dioxide | |
C12H9NO2S | 231.27 |
1209-61-6 | 4,9,12,12-四甲基-5-氧杂三环辛烷[8.2.0.04,6]十二烷 5-Oxatricyclo[8.2.0.04,6]dodecane,4,9,12,12-tetramethyl- | |
C15H26O | |
1209-31-0 | alpha-cyclobutyl-mandelic aci methyl ester | |
| |
1209-30-9 | n-ethyl-1,8,8-trimethylthio-3-azabicyclo(3.2.1)octane-3-carboxamid | |
| |
1209-14-9 | ((4-methoxyphenyl)hydrazono)-propanedinitril | |
| |
120893-72-3 | boc-lys(boc)-gly-oh | 密度:1.148±0.06 g/cm3(Predicted) 沸点:640.6±55.0 °C(Predicted)
|
C18H33N3O7 | 403.47 |
120890-05-3 | benzoic acid, 2-chloro-5-(3-(difluoromethyl)-3,6-dihydro-4-methyl-2,6-dioxo-1(2 | |
| |
12089-29-1 | diphenyl-chromium (iii iodide | |
C12H12CrI | 335.12 |
120889-17-0 | 1-(6-((2-methyl-2-nonyl-1,3-dioxolan-4-yl)methoxy)-6-oxohexyl)-pyridiniu br | |
| |
120889-16-9 | pyridinium, 1-(6-((2-heptadecyl-2-propyl-1,3-dioxolan-4-yl)methoxy)-6-oxohexyl) | |
| |